Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and …

J Xia, J Li, L Tian, X Ren, C Liu… - Journal of Medicinal …, 2022 - ACS Publications
Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that can change the
expression of downstream target genes by catalyzing the trimethylation of lysine 27 of …
被引用次数：13 相关文章

Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure-Activity Relationships Insights and …

J Xia, J Li, L Tian, X Ren, C Liu… - Journal of medicinal …, 2022 - pubmed.ncbi.nlm.nih.gov
Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that can change the
expression of downstream target genes by catalyzing the trimethylation of lysine 27 of …

Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure-Activity Relationships Insights and …

J Xia, J Li, L Tian, X Ren, C Liu… - Journal of Medicinal …, 2022 - europepmc.org
Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that can change the
expression of downstream target genes by catalyzing the trimethylation of lysine 27 of …